Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-METOPROLOL | 25MG | TABLET | Resolved | 2021-05-28 | 2021-06-28 | 140072 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-04 | 2021-06-28 | 140414 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-06-04 | 2021-06-22 | 140420 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-06-04 | 2021-06-21 | 140428 |
APO-SILDENAFIL | 25MG | TABLET | Resolved | 2021-06-04 | 2021-07-19 | 140431 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2021-06-04 | 2021-08-23 | 140434 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2021-06-11 | 2021-08-03 | 140767 |
APO-QUETIAPINE | 100MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140785 |
APO-QUETIAPINE | 200MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140788 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-06-18 | 2022-01-10 | 141234 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-06-18 | 2021-07-21 | 141241 |
APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-06-18 | 2021-09-20 | 141244 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-26 | 141515 |
APO-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2021-06-25 | 2021-08-31 | 141518 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2021-06-25 | 2021-10-05 | 141526 |
APO-IMATINIB | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-12 | 141532 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2021-06-25 | 2021-07-19 | 141537 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |
APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |